Trials / Completed
CompletedNCT02435524
Alive & Thrive Evaluation in Burkina Faso
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 4,541 (actual)
- Sponsor
- London School of Hygiene and Tropical Medicine · Academic / Other
- Sex
- Female
- Age
- 15 Years – 49 Years
- Healthy volunteers
- Accepted
Summary
The time between birth and age 24 months provides a unique opportunity to impact the long-term health and development of children through improved infant and young child feeding practices. In Burkina Faso, the prevalence of exclusive breastfeeding is currently around 25% in infants younger than six months. The purpose of this study is to evaluate whether the Alive \& Thrive intervention package, consisting of interpersonal counselling and community mobilisation activities, can increase the exclusive breastfeeding rate among infants younger than six months to at least 50% using a cluster randomised design.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | A&T infant and young child feeding intervention | 1. Interpersonal communication delivered by community workers and volunteers during home visits and at monthly mother's group meetings to: * Increase mother's knowledge about optimal breastfeeding and its benefits * Increase mother's self-efficacy related to breastfeeding * Improve mother's perceptions about social norms relating to breastfeeding 2. Community mobilisation activities to: \- Raise awareness of the benefits of optimal breastfeeding among opinion leaders, and family members, and increase the support they provide to breastfeeding mothers 3. Enhanced training of government health workers in infant and young child feeding to: * Improve their ability to support mothers and provide timely information about infant feeding |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2017-08-01
- Completion
- 2017-08-01
- First posted
- 2015-05-06
- Last updated
- 2018-12-04
- Results posted
- 2018-12-04
Locations
2 sites across 1 country: Burkina Faso
Source: ClinicalTrials.gov record NCT02435524. Inclusion in this directory is not an endorsement.